This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Mar;90(3):1897-9.

doi: 10.1210/jc.2005-0057.

Long-term safety of bisphosphonates

PMID: 15758064
DOI: 10.1210/jc.2005-0057

Editorial

Long-term safety of bisphosphonates

Susan M Ott. J Clin Endocrinol Metab. 2005 Mar.

. 2005 Mar;90(3):1897-9.

doi: 10.1210/jc.2005-0057.

Author

PMID: 15758064
DOI: 10.1210/jc.2005-0057

No abstract available

PubMed Disclaimer

Comment on

Severely suppressed bone turnover: a potential complication of alendronate therapy.
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Odvina CV, et al. J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301. doi: 10.1210/jc.2004-0952. Epub 2004 Dec 14. J Clin Endocrinol Metab. 2005. PMID: 15598694

Similar articles

Safety of bisphosphonates.
Orozco C, Maalouf NM. Orozco C, et al. Rheum Dis Clin North Am. 2012 Nov;38(4):681-705. doi: 10.1016/j.rdc.2012.09.001. Rheum Dis Clin North Am. 2012. PMID: 23137577 Review.
[Efficacy and safety of long-term treatment with bisphosphonate for osteoporosis in Japanese].
Kushida K. Kushida K. Nihon Rinsho. 2004 Feb;62 Suppl 2:455-60. Nihon Rinsho. 2004. PMID: 15035170 Review. Japanese. No abstract available.
Long-term use of bisphosphonates in osteoporosis.
Watts NB, Diab DL. Watts NB, et al. J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65. doi: 10.1210/jc.2009-1947. Epub 2010 Feb 19. J Clin Endocrinol Metab. 2010. PMID: 20173017 Review.
[Adverse effects of bisphosphonates].
Arboleya L, Alperi M, Alonso S. Arboleya L, et al. Reumatol Clin. 2011 May-Jun;7(3):189-97. doi: 10.1016/j.reuma.2010.10.005. Epub 2011 Mar 3. Reumatol Clin. 2011. PMID: 21794811 Review. Spanish.
Use of bisphosphonates in older adults: how long is long enough?
Dunn RL, Bird ML, Conway SE, Stratton MA. Dunn RL, et al. Consult Pharm. 2013 Jan;28(1):39-57. doi: 10.4140/TCP.n.2013.39. Consult Pharm. 2013. PMID: 23315281 Review.

See all similar articles

Cited by

The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy-Potential Implications in the Treatment of Osteogenesis Imperfecta.
Guo Q, Zhai Q, Ji P. Guo Q, et al. Pharmaceuticals (Basel). 2024 Sep 29;17(10):1297. doi: 10.3390/ph17101297. Pharmaceuticals (Basel). 2024. PMID: 39458939 Free PMC article. Review.
Atypical Metatarsal Fractures: Report of Five Clinical Cases.
Vasconcelos JW, Souza NM, Leite LMDS, Júnior JARC. Vasconcelos JW, et al. Rev Bras Ortop (Sao Paulo). 2024 Apr 19;59(Suppl 1):e119-e122. doi: 10.1055/s-0043-1770906. eCollection 2024 Jul. Rev Bras Ortop (Sao Paulo). 2024. PMID: 39027179 Free PMC article.
Effect of clodronate on gene expression in the peripheral blood of horses.
Wilcox CV, Knych HK, Katzman SA, Arthur RM, Rodriguez V, Finno CJ. Wilcox CV, et al. J Vet Pharmacol Ther. 2024 May;47(3):187-192. doi: 10.1111/jvp.13424. Epub 2024 Jan 10. J Vet Pharmacol Ther. 2024. PMID: 38197553
Bisphosphonates attenuate age-related muscle decline in Caenorhabditis elegans.
Slade L, Bollen SE, Bass JJ, Phillips BE, Smith K, Wilkinson DJ, Szewczyk NJ, Atherton PJ, Etheridge T. Slade L, et al. J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2613-2622. doi: 10.1002/jcsm.13335. Epub 2023 Sep 18. J Cachexia Sarcopenia Muscle. 2023. PMID: 37722921 Free PMC article.
Leucine Repeat Rich Kinase 1 Controls Osteoclast Activity by Managing Lysosomal Trafficking and Secretion.
Shen S, Si M, Zeng C, Liu EK, Chen Y, Vacher J, Zhao H, Mohan S, Xing W. Shen S, et al. Biology (Basel). 2023 Mar 29;12(4):511. doi: 10.3390/biology12040511. Biology (Basel). 2023. PMID: 37106712 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information